Tag:
Gen-Probe
Latest Headlines
Latest Headlines
Hologic to absorb Gen-Probe in $3.7B bid to be major STD diagnostics player
Hologic ($HOLX) will become a major player in molecular diagnostics focused on sexually transmitted diseases and boost its women's health expertise with its planned $3.7 billion cash acquisition of Gen-Probe ($GPRO).
FDA OKs Gen-Probe HPV test
The FDA has given its blessing to Gen-Probe's ( $GPRO ) APTIMA HPV assay, an amplified nucleic acid test that detects 14 high-risk HPV types associated with cervical cancer and precancerous lesions.
Novartis' interest in buying Gen-Probe fizzles, WSJ reports
Novartis' appetite for deals is expected to grow in the near future, but the Swiss drug giant ($NVS) may no longer be interested in gobbling up diagnostic test provider Gen-Probe. After speculation
Reports: Novartis no longer pursuing Gen-Probe
Novartis is reportedly no longer looking into buying diagnostic test maker Gen-Probe, the Wall Street Journal says, citing sources. Life Technologies and Thermo Fisher Scientific had also expressed
Will Novartis follow through with Gen-Probe bid?
Novartis CEO Joe Jimenez ( photo ) said last week that one prime dealmaking area for his company might be diagnostics. Along with potential buys in animal health, generics, biotech and consumer health,
Gen-Probe jumps on takeover speculation
San Diego-based Gen-Probe has jumped 18 percent on talk that it will be sold, and it may still be worth $1.3 billion more in a takeover by Novartis or Life Technologies, Bloomberg is reporting today.
Pacific Biosciences adds $109M to its venture haul
One of the richest tech startups in biotech history is adding even more millions to its cache of cash as it ramps up the commercialization of its DNA sequencing services. Pacific Biosciences says it
PacBio gets $50M investment from Gen-Probe
Pacific Biosciences--a company that's never had any trouble raising money --has received a $50 million investment from molecular diagnostics firm Gen-Probe . The funding is part of a larger Series F
Gen-Probe in deal-making mode
The San Diego Union-Tribune outlines Gen-Probe's potential in the diagnostics field, focusing on its $500 million bank account and a string of new deals that includes buying Tepnel and a renegotiated
Solvay ups bid for Innogenetics
It looks like Solvay, not Gen-Probe , will be buying Belgium's Innogenetics. Back in April Solvay made a
